City of Hope To Use Sequenom's MassArray Platform | GenomeWeb
NEW YORK (GenomeWeb News) - The City of Hope National Medical Center has purchased Sequenom's MassArray genetic analysis system and portfolio of application tools, Sequenom said today.
 
City of Hope will use MassArray for its molecular marker research and individualized cancer care initiatives, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.